샘플 요청 목록

 카트 문의
시장보고서
상품코드
1777629

세계의 독성 시험 아웃소싱 시장

Toxicity Testing Outsourcing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 369 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 독성 시험 아웃소싱 시장은 2030년까지 56억 달러에 도달

2024년에 36억 달러로 추정되는 세계의 독성 시험 아웃소싱 시장은 2024-2030년에 CAGR 7.5%로 성장하며, 2030년에는 56억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 In-Vitro는 CAGR 6.0%를 기록하며, 분석 기간 종료시에는 31억 달러에 달할 것으로 예측됩니다. 생체내 부문의 성장률은 분석 기간에 CAGR 9.6%로 추정됩니다.

미국 시장은 9억 8,060만 달러로 추정, 중국은 CAGR 11.5%로 성장 예측

미국의 독성 시험 아웃소싱 시장은 2024년에 9억 8,060만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 12억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 11.5%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 3.9%와 7.1%로 예측됩니다. 유럽에서는 독일이 CAGR 5.0%로 성장할 것으로 예측됩니다.

독성 시험 아웃소싱 시장 동향과 촉진요인 정리

독성 시험 아웃소싱이 의약품의 안전과 규제 준수를 어떻게 강화할 수 있는가?

독성시험은 신약, 화학물질, 소비재 제품의 안전성과 유효성을 보장하는 의약품 개발의 중요한 단계입니다. 독성시험을 전문 CRO(임상시험 수탁기관)에 위탁하는 것은 제약회사 및 바이오테크놀러지 기업에게 비용 절감, 연구개발 기간 단축, 엄격한 규제 요건을 극복할 수 있는 전략적인 접근 방식입니다. 안전성 평가 프로토콜의 복잡성은 in vitro 및 컴퓨터 독성 시험의 발전과 함께 외부 전문가에 대한 수요를 증가시키고 있습니다. 또한 동물실험을 대체할 수 있는 윤리적 대안을 찾는 움직임은 장기 칩과 AI를 활용한 예측 모델링의 개발로 이어져 시장을 더욱 변화시키고 있습니다. 그러나 데이터 무결성, 표준화, 여러 관할권에 걸친 규제 준수에 대한 우려는 여전히 과제로 남아있습니다. 독성 시험이 진화하는 가운데, 아웃소싱 파트너십은 어떻게 혁신을 촉진하고 차세대 치료제의 안전성을 보장할 수 있는가?

어떤 기술 혁신이 독성 시험 아웃소싱을 발전시키고 있는가?

독성시험의 최첨단 개발에는 AI를 활용한 독성 예측 모델, 하이스루풋 스크리닝(HTS), 인체 장기계를 모방한 3D 세포배양 모델 등이 있습니다. 머신러닝 알고리즘은 방대한 데이터세트를 분석하여 의약품 개발 초기 단계에서 잠재적인 안전성 위험을 식별함으로써 독성 평가에 혁명을 일으키고 있습니다. 마이크로플루이딕스 장기 칩 플랫폼과 같은 in vitro 시험법은 동물 모델에 대한 의존도를 낮추는 동시에 보다 인간과 관련된 독성 데이터를 제공합니다. 또한 블록체인 기술은 데이터 추적성 및 규제 준수를 위해 검토되고 있으며, 전 세계 독성 시험 네트워크 전체의 투명성과 표준화를 보장하고 있습니다.

독성 시험 아웃소싱에 대한 수요가 증가하는 이유는 무엇인가?

의약품 안전성에 대한 규제 당국의 감시 강화, 의약품 개발 파이프라인의 복잡성 증가, 대체 시험법 채택 증가 등이 독성 시험 서비스 아웃소싱 수요를 촉진하고 있습니다. 제약사들은 진화하는 안전 표준을 준수할 수 있는 비용 효율적인 솔루션을 우선시하고 있습니다. 또한 맞춤형 의료와 생물제제로의 전환으로 인해 보다 전문적인 독성 평가가 필요해지면서 아웃소싱의 추세를 더욱 부추기고 있습니다.

독성 시험 아웃소싱 시장의 성장을 가속하는 요인은 무엇인가?

예측 독성학의 발전, AI를 활용한 안전성 평가 툴의 채택 확대, 화학물질 및 의약품 안전에 대한 규제 요건 강화, 비용 효율적인 아웃소싱 솔루션에 대한 수요 증가 등이 시장 확대에 기여하고 있습니다. 제약회사들이 엄격한 안전기준을 충족시키면서 효율성을 높이기 위해 노력하는 가운데, 독성시험에서 CRO의 역할은 의약품 개발 및 규제준수의 미래를 형성하는 데 있으며, 점점 더 중요해질 것으로 예측됩니다.

부문

시험법(in-vitro, in-vivo); GLP 유형(GLP, 비GLP); 최종사용자(제약·바이오파마 기업, 학술·연구기관, 기타)

조사 대상 기업의 예

  • ALS Limited
  • BioReliance(Merck KGaA)
  • Catalent, Inc.
  • Charles River Laboratories
  • Covance Inc.(Labcorp Drug Development)
  • Creative Bioarray
  • Cyprotex(Evotec)
  • Eurofins Scientific
  • Evotec SE
  • Frontage Laboratories
  • GenScript Biotech Corporation
  • ICON plc
  • Intertek Group plc
  • IQVIA
  • Labcorp Drug Development
  • Lonza Group
  • Medpace, Inc.
  • PPD, Inc.(Thermo Fisher Scientific)
  • Promega Corporation
  • SGS SA
  • Syngene International Limited
  • Toxikon Corporation

AI 통합

당사는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.05

Global Toxicity Testing Outsourcing Market to Reach US$5.6 Billion by 2030

The global market for Toxicity Testing Outsourcing estimated at US$3.6 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. In-Vitro, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the In-Vivo segment is estimated at 9.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$980.6 Million While China is Forecast to Grow at 11.5% CAGR

The Toxicity Testing Outsourcing market in the U.S. is estimated at US$980.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 11.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 7.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Toxicity Testing Outsourcing Market Trends & Drivers Summarized

How Is Outsourcing Toxicity Testing Enhancing Drug Safety and Regulatory Compliance?

Toxicity testing is a critical step in drug development, ensuring the safety and efficacy of new pharmaceuticals, chemicals, and consumer products. Outsourcing toxicity testing to specialized contract research organizations (CROs) has become a strategic approach for pharmaceutical and biotechnology firms, allowing them to reduce costs, accelerate development timelines, and navigate stringent regulatory requirements. The increasing complexity of safety assessment protocols, coupled with advancements in in vitro and computational toxicity testing, is driving demand for external expertise. Additionally, the push for ethical alternatives to animal testing has led to the development of organ-on-a-chip and AI-driven predictive modeling, further transforming the market. However, concerns regarding data integrity, standardization, and regulatory compliance across different jurisdictions remain challenges. As toxicity testing evolves, how will outsourcing partnerships drive innovation and ensure the safety of next-generation therapeutics?

What Technological Innovations Are Advancing Toxicity Testing Outsourcing?

Cutting-edge developments in toxicity testing include AI-powered toxicity prediction models, high-throughput screening (HTS), and 3D cell culture models that mimic human organ systems. Machine learning algorithms are revolutionizing toxicity assessment by analyzing vast datasets and identifying potential safety risks early in drug development. In vitro testing methods, such as microfluidic organ-on-a-chip platforms, are reducing reliance on animal models while providing more human-relevant toxicity data. Additionally, blockchain technology is being explored for data traceability and regulatory compliance, ensuring transparency and standardization across global toxicity testing networks.

Why Is the Demand for Toxicity Testing Outsourcing Increasing?

The growing regulatory scrutiny of pharmaceutical safety, increasing complexity of drug development pipelines, and rising adoption of alternative testing methods are driving demand for outsourced toxicity testing services. Pharmaceutical companies are prioritizing cost-effective solutions that ensure compliance with evolving safety standards. Additionally, the shift toward personalized medicine and biologics is requiring more specialized toxicity evaluation, further boosting outsourcing trends.

What Factors Are Driving the Growth of the Toxicity Testing Outsourcing Market?

The market is expanding due to advancements in predictive toxicology, increasing adoption of AI-driven safety assessment tools, growing regulatory requirements for chemical and pharmaceutical safety, and rising demand for cost-effective outsourcing solutions. As drug developers seek to improve efficiency while meeting strict safety standards, the role of CROs in toxicity testing is expected to become increasingly vital in shaping the future of drug development and regulatory compliance.

SCOPE OF STUDY:

The report analyzes the Toxicity Testing Outsourcing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Method (In-Vitro, In-Vivo); GLP Type (GLP, Non-GLP); End-Use (Pharma & Biopharma Companies, Academic & Research Institutes, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • ALS Limited
  • BioReliance (Merck KGaA)
  • Catalent, Inc.
  • Charles River Laboratories
  • Covance Inc. (Labcorp Drug Development)
  • Creative Bioarray
  • Cyprotex (Evotec)
  • Eurofins Scientific
  • Evotec SE
  • Frontage Laboratories
  • GenScript Biotech Corporation
  • ICON plc
  • Intertek Group plc
  • IQVIA
  • Labcorp Drug Development
  • Lonza Group
  • Medpace, Inc.
  • PPD, Inc. (Thermo Fisher Scientific)
  • Promega Corporation
  • SGS SA
  • Syngene International Limited
  • Toxikon Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Toxicity Testing Outsourcing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Regulatory Scrutiny and Safety Requirements Drive Toxicity Testing Demand
    • Growth in Biopharmaceutical and Agrochemical Pipelines Fuels Outsourcing of Preclinical Testing
    • Cost and Time Pressures Push Sponsors to Engage Specialized CROs for Toxicology Studies
    • Shift Toward In Vitro and Alternative Testing Models Supports Innovation in Assay Platforms
    • Increasing Adoption of High-Throughput Screening Enhances Outsourcing Efficiency
    • Expansion of GLP-Compliant Testing Facilities Across Asia-Pacific Improves Global Access
    • Complexity of Multi-Species and Long-Term Studies Encourages Outsourced Execution
    • Advancements in Organoids and Organ-on-a-Chip Models Gain CRO Integration
    • AI-Based Predictive Toxicology Platforms Strengthen Risk Assessment Capabilities
    • Consolidation of CROs and CDMOs Supports End-to-End Toxicity and Regulatory Services
    • Growing Demand for Genetic, Reproductive, and Environmental Toxicity Testing Broadens Scope
    • Rising R&D in Cosmetics and Nutraceuticals Expands Demand for Non-Animal Safety Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Toxicity Testing Outsourcing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Toxicity Testing Outsourcing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Toxicity Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for In-Vitro by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for In-Vitro by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for In-Vitro by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for In-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for In-Vivo by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for In-Vivo by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for GLP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for GLP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for GLP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Non-GLP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Non-GLP by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Non-GLP by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Toxicity Testing Outsourcing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Toxicity Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: France 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: France 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Germany 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Germany 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Germany 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Italy 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Italy 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Italy 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: UK 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: UK 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: UK 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Spain 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Spain 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Spain 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Russia 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Russia 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Russia 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Toxicity Testing Outsourcing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Toxicity Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Australia 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Australia 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Australia 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: India 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: India 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: India 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: South Korea 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: South Korea 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: South Korea 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Toxicity Testing Outsourcing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Latin America 15-Year Perspective for Toxicity Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Latin America 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Latin America 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Argentina 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Argentina 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Argentina 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Brazil 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Brazil 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Brazil 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Mexico 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Mexico 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Mexico 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Toxicity Testing Outsourcing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Middle East 15-Year Perspective for Toxicity Testing Outsourcing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Middle East 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Middle East 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Iran 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Iran 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Iran 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Israel 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Israel 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Israel 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: UAE 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: UAE 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: UAE 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Toxicity Testing Outsourcing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Toxicity Testing Outsourcing by Method - In-Vitro and In-Vivo Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Africa 15-Year Perspective for Toxicity Testing Outsourcing by Method - Percentage Breakdown of Value Sales for In-Vitro and In-Vivo for the Years 2015, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Toxicity Testing Outsourcing by GLP Type - GLP and Non-GLP Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Africa 15-Year Perspective for Toxicity Testing Outsourcing by GLP Type - Percentage Breakdown of Value Sales for GLP and Non-GLP for the Years 2015, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Toxicity Testing Outsourcing by End-Use - Pharma & Biopharma Companies, Academic & Research Institutes and Others Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Africa 15-Year Perspective for Toxicity Testing Outsourcing by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academic & Research Institutes and Others for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제